Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M221Revenue $M15.5Net Margin (%)-91.0Z-Score2.5
Enterprise Value $M86.8EPS $-0.8Operating Margin %-78.6F-Score3
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-91.0Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %0Quick Ratio6.0Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %-1.1Current Ratio6.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-19.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-23.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M22.1ROI % (ttm)148Gross Margin Increase y-yN

Gurus Latest Trades with TKMR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TKMRJean-Marie Eveillard 2013-06-30 Sold Out $4.28 - $5.05
($4.74)
$ 10.02111%Sold Out0
TKMRJean-Marie Eveillard 2013-03-31 Buy $4.35 - $5.44
($4.73)
$ 10.02112%New holding, 25000 sh.25,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TKMR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


TKMR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Jewell, DonaldDirector 2013-08-06Buy400$6.164.26 view
Jewell, DonaldDirector 2013-08-06Buy400$6.0964.53 view
Jewell, DonaldDirector 2013-08-06Buy500$6.164.26 view
Jewell, DonaldDirector 2013-08-06Buy300$6.0964.53 view
Murray, Mark JosephSenior Officer 2013-04-16Buy5,000$4.6117.83 view
Jewell, DonaldDirector 2013-03-12Buy1,200$4.44125.68 view
Jewell, DonaldDirector 2013-02-01Buy5,500$4.73111.84 view

Press Releases about TKMR :

    Quarterly/Annual Reports about TKMR:

    News about TKMR:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Jul 22 2014
    Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A Buying Opportunity? Jul 22 2014
    Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold Jul 21 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events Jul 21 2014
    12:21 pm Tekmira Pharma provides update on TKM-Ebola Phase I clinical hold; the co anticipates this... Jul 21 2014
    Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold Jul 21 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 10 2014
    Tekmira Receives $1.5 Million Milestone Payment Jul 10 2014
    Tekmira receives $1.5M milestone payment from Monsanto Jul 09 2014
    Tekmira Receives $1.5 Million Milestone Payment Jul 09 2014
    Tekmira Sinks 15%; Anti-Ebola Drug Trial Halted For Safety Concerns Jul 03 2014
    Why Tekmira Pharmaceuticals (TKMR) Stock Is Plunging Today Jul 03 2014
    Stocks to Watch: Lululemon, Bind Therapeutics, Regado Biosciences Jul 03 2014
    Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial Jul 03 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 03 2014
    Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial Jul 03 2014
    Giving cells instructions to fight disease Jun 17 2014
    Stunning Potential For Upside In Canadian Biotech: Brian Bloom Jun 13 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 27 2014
    Tekmira initiating Phase I/II clinical trial evaluating TKM-PLK1 May 27 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide